troglitazone has been researched along with transforming growth factor beta in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, T; Horikoshi, H; Miyadai, K; Ohsumi, J; Sakakibara, S; Serizawa, N; Yamaguchi, J; Yoshioka, S | 1 |
| Haneda, M; Isshiki, K; Kikkawa, R; Koya, D; Maeda, S; Sugimoto, T | 1 |
| Fazio, S; Fogo, AB; Linton, MF; Ma, LJ; Marcantoni, C | 1 |
| Bierhaus, A; Brodbeck, K; Häring, HU; Schleicher, ED; Weigert, C | 1 |
| Baek, SJ; DiAugustine, RP; Eling, TE; Kim, JS; Nixon, JB | 1 |
| Bruno, MJ; Daalhuisen, J; de Boer, AM; de Vos, AF; Florquin, S; van der Poll, T; van Westerloo, DJ | 1 |
| Birgel, M; Hauner, H; Lee, YM; Skurk, T | 1 |
| Chen, N; Liu, F; Wang, WM | 1 |
| Li, F; Shi, J; Song, J; Wang, D; Zhou, Y | 1 |
| Liu, F; Peng, YM; Wei, JL | 1 |
| Blümcke, I; Buslei, R; Coras, R; Eyüpoglu, IY; Hahnen, E; Hauke, J; Hölsken, A; Reichel, M; Seufert, S; Siebzehnrübl, FA; Tränkle, C | 1 |
| Belperio, JA; Burdick, MD; Hong, KM; Keane, MP; Strieter, RM | 1 |
| Chen, SL; Cheng, HC; Ho, TC; Hong, KF; Lai, HY; Tsao, YP | 1 |
| Han, M; He, Y; Huang, Q; Jiang, JJ; Liu, XC; Xu, G; Yao, Y; Zou, R | 1 |
| Bork, P; Iskar, M; Koch, M; Ostertag, K; Schölch, S; Schweitzer, C; van Noort, V; Weitz, J; Werner, K; Zeller, G | 1 |
| Duan, J; Hu, C; Zhang, Q; Zhu, J | 1 |
16 other study(ies) available for troglitazone and transforming growth factor beta
| Article | Year |
|---|---|
Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.
Topics: 3T3 Cells; Adipocytes; Animals; Blood Glucose; Cell Differentiation; Chromans; Cytokines; Drug Interactions; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Insulin; Interleukin-1; Interleukin-6; Lymphokines; Mice; Monosaccharide Transport Proteins; Muscle Proteins; Thiazoles; Thiazolidinediones; Transcription Factor AP-1; Transforming Growth Factor beta; Troglitazone; Tumor Necrosis Factor-alpha | 1994 |
Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats.
Topics: Albuminuria; Animals; Chromans; Diabetes Mellitus, Experimental; Diglycerides; Extracellular Matrix Proteins; Hemodynamics; Insulin; Kidney Glomerulus; Male; Mitogen-Activated Protein Kinases; Pioglitazone; Protein Kinase C; Rats; Rats, Sprague-Dawley; Renal Circulation; RNA, Messenger; Thiazoles; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2000 |
Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Topics: Animals; Antihypertensive Agents; Base Sequence; Chromans; Disease Models, Animal; DNA Primers; Glomerulosclerosis, Focal Segmental; Hypoglycemic Agents; Insulin Resistance; Kidney; Lipids; Macrophages; Male; Nephrectomy; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transforming Growth Factor beta; Troglitazone | 2001 |
c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones.
Topics: Animals; Cells, Cultured; Chromans; Glucose; Hydrogen Peroxide; Mice; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Swine; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Troglitazone | 2003 |
Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Chromans; Cytokines; DNA-Binding Proteins; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Growth Differentiation Factor 15; Humans; Immediate-Early Proteins; Ligands; Luciferases; Models, Biological; Models, Genetic; Multigene Family; Oligonucleotides; Phosphorylation; Plasmids; Promoter Regions, Genetic; Prostaglandin D2; Protein Binding; Receptors, Cytoplasmic and Nuclear; RNA; Sp1 Transcription Factor; Thiazolidinediones; Time Factors; Transcription Factors; Transcriptional Activation; Transfection; Transforming Growth Factor beta; Troglitazone; Up-Regulation | 2004 |
Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice.
Topics: Actins; Animals; Cell Differentiation; Ceruletide; Chromans; Chronic Disease; Collagen; Disease Models, Animal; Fibrosis; Inflammation; Interleukin-6; Ligands; Mice; Mice, Inbred C57BL; Muscle, Smooth; Pancreatitis; Platelet Aggregation Inhibitors; PPAR gamma; Receptors, Tumor Necrosis Factor, Type I; Sodium Chloride; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1; Troglitazone | 2005 |
Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
Topics: Adipocytes; Adult; Cell Culture Techniques; Cell Differentiation; Chromans; Gene Expression Regulation; Glucose; Humans; Hypoglycemic Agents; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone; Tumor Necrosis Factor-alpha | 2006 |
[Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Topics: Animals; Blotting, Far-Western; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Kidney; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
Different roles of protein kinase C-betaI and -delta in the regulation of adipocyte differentiation.
Topics: 3T3-L1 Cells; Acetophenones; Adipocytes; Adipogenesis; Animals; Benzopyrans; Carbazoles; Cell Differentiation; Cell Membrane; Cell Proliferation; Chromans; Cytosol; Epidermal Growth Factor; Gene Expression; Genes, Dominant; Indoles; Mice; Mutant Proteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Protein Transport; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
Connective tissue growth factor and fibronectin secretion in renal tubular epithelial cells induced by TGF-beta1: suppressive effects of troglitazone.
Topics: Cells, Cultured; Chromans; Connective Tissue Growth Factor; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fibronectins; Formazans; Gene Expression; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney Tubules, Proximal; RNA, Messenger; Tetrazolium Salts; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2007 |
The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.
Topics: Animals; Base Sequence; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Chromans; DNA Primers; Down-Regulation; G1 Phase; Glioma; Mice; Neoplasm Invasiveness; PPAR gamma; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2007 |
Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma.
Topics: Actins; Adipocytes; Cell Differentiation; Chromans; Connective Tissue Cells; Enzyme Inhibitors; Fibroblasts; Humans; Leukocytes, Mononuclear; MAP Kinase Kinase 4; MAP Kinase Signaling System; Models, Biological; PPAR gamma; Thiazolidinediones; Transcriptional Activation; Transforming Growth Factor beta; Troglitazone | 2007 |
Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells.
Topics: Cell Line; Cell Movement; Chromans; Collagen Type I; Enzyme Activation; Fibronectins; Fibrosis; Humans; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pigment Epithelium of Eye; PPAR gamma; RNA, Messenger; Signal Transduction; Smad2 Protein; Smad3 Protein; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2008 |
PPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis.
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Chromans; Collagen Type IV; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Glomerular Mesangium; Glomerulonephritis; Hypoglycemic Agents; PPAR gamma; Rats; Signal Transduction; Telmisartan; Thiazolidinediones; Transfection; Transforming Growth Factor beta; Troglitazone | 2010 |
Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling.
Topics: Animals; Antineoplastic Agents; Chromans; Citalopram; Colorectal Neoplasms; Gene Expression Profiling; HCT116 Cells; HT29 Cells; Humans; Imidazoles; Mice, Inbred NOD; Neoplastic Cells, Circulating; Signal Transduction; Thiazolidinediones; Transcriptome; Transforming Growth Factor beta; Troglitazone; Xenograft Model Antitumor Assays | 2014 |
Exploration of the Effects of TGF-
Topics: Animals; Cell Line; Chromans; Male; Matrix Metalloproteinase 9; Pituitary Neoplasms; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1; Troglitazone | 2022 |